Could Nanotechnology Help to End the Fight Against COVID-19? Review of Current Findings, Challenges and Future Perspectives

A serious viral infectious disease was introduced to the globe by the end of 2019 that was seen primarily from China, but spread worldwide in a few months to be a pandemic. Since then, accurate prevention, early detection, and effective treatment strategies are not yet outlined. There is no approved drug to counter its worldwide transmission. However, integration of nanostructured delivery systems with the current management strategies has promised a pronounced opportunity to tackle the pandemic. This review addressed the various promising nanotechnology-based approaches for the diagnosis, prevention, and treatment of the pandemic. The pharmaceutical, pharmacoeconomic, and regulatory aspects of these systems with currently achieved or predicted beneficial outcomes, challenges, and future perspectives are also highlighted.

Automated summary

This review discusses promising nanotechnology-based approaches for the diagnosis, prevention, and treatment of the pandemic, highlighting the importance of integrating nanostructured delivery systems with current management strategies to combat the global spread of the virus. It also emphasizes the achieved or predicted beneficial outcomes, challenges, and future perspectives in the pharmaceutical, pharmacoeconomic, and regulatory aspects of these systems.